Heart in Diabetes 8th Annual Heart in Diabetes Conference 2024
Format: 44 videos, size: 11.3 GB
Course Audience: diabetologists, cardiologists, family physicians, nephrologists, internist, endocrinologist
Overview:
8th Annual Heart in Diabetes (HiD) CME Conference is organized by The Metabolic Institute of America (TMIOA) and will be held from Jun 07 – 09, 2024 at Hilton Philadelphia at Penn’s Landing, Philadelphia, Pennsylvania, United States of America.
Learning Objectives:
Upon completion of this meeting, participants should be able to:• Evaluate the extent of vascular disease in diabetes, obesity, and cardiometabolic syndrome.• Be able to assess cardiovascular risk in diabetes.• Describe the different etiologies of cardiomyopathies.• Provide comprehensive management of diabetes, addressing obesity, hypertension, dyslipidemia as well as hyperglycemia.• Describe optimal use of technology—specifically CGM—and digital technology and their impact on diabetes and CVD• Be able to recognize and manage hypoglycemia and its impact on comorbidities• Evaluate stroke in diabetes and cardiorenal metabolic disease• Be able to evaluate prevent and manage atherosclerosis and ASCVD• Recognize the full spectrum of Heart Failure dictating approach to management• Know GDMT in the 4 Pillar management of HFrEF• Develop contemporary management of HFpEF• Discuss the impact of obesity and diets on fatty liver, CKD, CVD, and HF• Evaluate the evidence supporting the use of GLP1-RAs, SGLT inhibitors, nonsteroidal MRAs, and other treatments to reduce CKD, HF, and cardiovascular disease and mortality in patients with T2D• Describe new and evolving agents in dyslipidemia treatment and how they can be used to reduce ASCVD• Explain the important role of Lp(a) in the development atherosclerosis• Understand the potential role and impact of AHA Presidential Advisory on Cardio-Kidney-Metabolic Health• Discuss the changes in diagnosis and management based on DCRM 2.0 Global Multispecialty Practice Recommendations• Evaluate the impact on clinical practice of new CVOTs, including those evaluating antihyperglycemic, lipid-lowering, and other medications such as nonsteroidal MRAs and anticoagulation therapies• Understand the role of GLP1-RAs in prevention of CVD, strokes, and CKD in diabetes and obesity• Describe the state of heart disease in women• Discuss diabetes, CKD, CVD, and HF in diverse populations• Develop treatment plans to prevent and manage CKD and its complications with ACE/ARB, SGLT inhibitors, finerenone, and GLP1-RAs in combination.TARGET AUDIENCE
Pharmacist, Physician Assistant, Diabetologists, Cardiologists, Family Physicians, Nephrologists, Residents, Nurses, Internist, Dietitian, Medical Students, Endocrinologist, Nurse Practitioners, Fellows, Other health Professionals
SPECIALITIES
Endocrinology, Metabolism and Diabetes, Cardiology
AHA CKM Health Initiative The Nephrology Perspective (Video MP4 Format)
An Overview of Cardiovascular-Kidney-Metabolic (CKM) Health (Video MP4 Format)Atherothrombotic Risk Stratification in Patients With Type 2 Diabetes (Video MP4 Format)Beyond 10-Year Risk New Paradigms for Long-Term Risk Estimation With AHA PREVENT (Video MP4 Format)Cardiovascular Disease in the Very Old (Video MP4 Format)Cardiovascular Outcomes in GRADE – The Impact of Antihyperglycemic Agents in Lower Risk Patients With Type 2 Diabetes (Video MP4 Format)Clinical Interventions in Atherosclerosis (Video MP4 Format)CRM in Amyloidosis (Video MP4 Format)Diabetic Foot Ulcers in the Cardiovascular Patient Population An AHA Scientific Statement (Video MP4 Format)Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease (Video MP4 Format)Estimated Lifetime Benefits of SGLT2i, GLP-1RA, and Non-Steroidal MRAs in People With Type 2 Diabetes and Albuminuria (Video MP4 Format)Exercise in Diabetes Care – From CV Outcomes to Longevity (Video MP4 Format)FLOW – The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist (Video MP4 Format)Functional Hypothalamic Amenorrhea Consequences Beyond the Menstrual Cycle (Video MP4 Format)Gestational Diabetes and Future Cardiovascular Disease in Women (Video MP4 Format)GLP1-RA and Risk of Stroke (Video MP4 Format)Guideline Recommended Therapy in Patients With Diabetic Kidney Disease (Video MP4 Format)HDL-C Helpful, Harmful, Hopeful, or Guilty by Association (Video MP4 Format)Heart Failure Post Myocardial Infraction and Valvular Disease (Video MP4 Format)Hypertension and Hyperglycemia Twin Sisters Masquerading as Cushing Syndrome (Video MP4 Format)Hypertension Awakenings Finally Something New to Talk About (Video MP4 Format)Impact of Cumulative Risk Factor Exposure on Incident Cardiovascular Disease (Video MP4 Format)Integrating Wearables, Behavior and AI to Improve Metabolic Health (Video MP4 Format)Ketone Metabolism and the Human Heart Implications for Heart Failure (Video MP4 Format)Lp(a) in ASCVD – What We Know, Should Know and Want to Know (Video MP4 Format)Medical Treatment of Hypercortisolism With Relacorilant Final Results of the Phase 3 GRACE Study (Video MP4 Format)Metabolic Dysfunction Associated Steatohepatitis Advancing the Understanding of Underlying Mechanisms, Diagnostic Approach and Therapeutic Strategies (Video MP4 Format)Modifying Cardiovascular Risk Associated With CKD in T2D With Finerenone (Video MP4 Format)New Emerging Treatment for DKD (Video MP4 Format)New Targets and Upcoming Medications for Dyslipidemia (Video MP4 Format)Optimal Strategy for HF Screening Among Adults With Diabetes Without ASCVD A Pooled Cohort Analysis (Video MP4 Format)Outcome of Advanced CKD Without Albuminuria Impact of SGLT2i and GLP-1 RA (Video MP4 Format)Predicting and Preventing Hospital Admissions in Patients With Heart Failure It’s Really Difficult (Video MP4 Format)SELECT GLP1 RA Impact on ASCVD in Obesity Without Diabetes (Video MP4 Format)Simultaneous vs. Sequential Start of Foundation Therapies in CKD (Video MP4 Format)Social Isolation, Loneliness, and Diabetes (Video MP4 Format)Stroke vs. CAD Disparities in Risk Factor Management (Video MP4 Format)Technology in the Management of Diabetes (Video MP4 Format)The Contemporary Management of Heart Failure (Video MP4 Format)The Different Etiologies of Cardiomyopathy (Video MP4 Format)The Dynamic Duo GLP-1 Receptor Agonists and SGLT2 Inhibitors (Video MP4 Format)The Multiplying Effect of T2D With CKD on the Spectrum of Heart Disease and Mortality (Video MP4 Format)The Proper Management of a Patient With Heart Failure Circa 2024 (Video MP4 Format)When Weight is a Barrier to Transplant Managing Obesity in Patients With Advanced HF (Video MP4 Format)